[1] |
ZHAO Lingzhi, HE Yanjun, XIE Jianqin, YOU Chongge.
Research progress on therapeutic role of recombinant human soluble thrombomodulin in atherosclerosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 832-840.
|
[2] |
LIANG Hongyu, ZHANG Hailin, YIN Huanxin, CHEN Fan, LU Junlin, ZHU Caihong, HU Wei, ZHOU Renpeng.
Effects of 2-APB in skin wound healing in mice through down-regulation of TRPM7
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 747-753.
|
[3] |
MAO Shuying, JIN Wei, FU Sisi, LIU Keanqi, ZHOU Zhihao, WANG Guangji, LIANG Yan.
Oral lienal peptides improve ammonia-induced coughing and inflammation in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 601-607.
|
[4] |
JIN Yiyi, ZHOU Keting, YANG Chengcheng, XU Ping, ZHU Suyan.
Osthole attenuates diabetes-induced renal injury by regulating NF-κB and p38/MAPK pathway mediated inflammatory responses
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 622-631.
|
[5] |
CHANG Shufu .
Progress of medical treatment of coronary heart disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 405-408.
|
[6] |
WEI Jifang, YUE Hongmei, LIU Nanyu, SONG Peipei, XIE Yingying, WANG Jiaqi, WEI Yaqian.
Research progress on the relationship between thyroid hormone and idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 307-313.
|
[7] |
CHEN Yu, GU Bing, LI Huanan.
Modulating gut miocrobiota: a new strategy in the treatment of gout
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1307-1314.
|
[8] |
CHEN Yugang, TU Yanqiong, WANG Congqing, CHEN Juan, ZHANG Bohong.
Network pharmacology and molecular docking to discuss the mechanism of Jinhutongdan prescription in the treatment of cholelithiasis and experimental verification
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1090-1098.
|
[9] |
LI Ying, YAO Wei, WANG Meng, YU Zhihong, GONG Yuanqi, LAN Haibing, QI Xiefei.
Experimental study of irisin alleviates house dust mite-induced airway epithelial cells inflammation and apoptosis via the NF-κB and JNK signaling pathways
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1106-1112.
|
[10] |
ZHOU Shiqin, LUO Yali, ZHOU Wen, Qi Xiaofeng, XIAO Mengyong.
Molecular mechanism and treatment of pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1133-1147.
|
[11] |
WU Lin, HAO Yingxiang, ZHANG Lei, ZHANG Tianxue, GAO Mingjing, LENG Yufang.
Paricalcitol attenuates intestinal ischemia-reperfusion injury in mice through HMGB1/TLR4/NF-κB signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 1-7.
|
[12] |
ZHAN Zhuqin, BAI Haitao.
Effects of different doses of dexamethasone on angiotensin II, its receptors and NO levels in septic kidney injury rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 995-1004.
|
[13] |
WANG Rui, PAN Jinjin, LI Hua, YUAN Yuhui.
Research progress of melatonin on pulmonary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 444-448.
|
[14] |
ZHANG Na, TANG Futian.
Protective effect and mechanism of lycium barbarum polysaccharides on diabetic renal injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(11): 1237-1243.
|
[15] |
LI Jiadan,LU Chen.
Synergistic effects of Cortex Mori alkaloids combined with Simvastatin in rats with hyperlipidaemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 278-284.
|